Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Chinese Researchers Publish Comparisons Of BGISEQ-500, HiSeq2500

    Apr 5, 2017, 11:50 AM by Michael Croft

    Bio-IT World Brief | Researchers from China’s National Institutes for Food and Drug Control have published reference data of the BGISEQ-500 sequencing platform compared to Illumina’s HiSeq2500 platform.

    Full story
  • Elsevier Launches Reaxys ChemSearch Challenge and Engineering Academic Challenge for the Next Generation of Chemists and Engineers

    Apr 5, 2017, 11:32 AM by Michael Croft
    - Apr 5, 2017 - New York, April 5, 2017, Elsevier, the information analytics company specializing in science and health, has announced the launch of two game-based learning challenges, the Reaxys ChemSearch Challenge (CSC) and the Engineering Academic Challenge (EAC)
    Full story
  • How The Genomics Revolution Could Finally Help Africa

    Apr 5, 2017, 11:01 AM by Michael Croft
    Nature News & Comment | New investments promise to get precision medicine and precision public health off the ground. But experts debate how much work needs to be done first.
    Full story
  • Certara’s d3 Medicine Partners with the Australian Department of Defence to Audit the Nation’s Medical Countermeasures Preparedness

    Apr 5, 2017, 09:35 AM by Michael Croft
    PRINCETON - Apr 5, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that its d3 Medicine company has been selected to conduct a national audit of Australia’s medical countermeasures (MCM) product research and development (R&D) capabilities and capacity
    Full story
  • Qumulo Led by Isilon Execs Raises $30M to Push Data Storage Sales

    Apr 4, 2017, 16:26 PM by Michael Croft
    Xconomy | Qumulo's founders, leadership team, and investors are all betting that the Seattle data storage technology provider can deliver a repeat of another local success story.
    Full story
  • 2017 Benjamin Franklin Award Winner Announced

    Apr 4, 2017, 12:45 PM by Michael Croft

    Bio-IT World Brief | Rafael Irizarry, of Harvard University and the Dana Farber Cancer Institute, has been chosen as the 2017 laureate of the 2017 Benjamin Franklin Award in the Life Sciences.

    Full story
  • Web’s Inventor Tim Berners-Lee Wins The Nobel Prize Of Computing

    Apr 4, 2017, 11:31 AM by Michael Croft
    MIT Technology Review | Tim Berners-Lee has been awarded the ACM Turing Prize. Berners-Lee says Web access is a human right-and the technology he created needs a rethink.
    Full story
  • Precision NanoSystems NanoAssemblr™ chosen for Horizon 2020 project to develop novel RNA therapeutics

    Apr 4, 2017, 08:08 AM by Michael Croft
    VANCOUVER, BC, CANADA - Apr 4, 2017 - Precision NanoSystems NanoAssemblr™ platform has been selected for the controlled manufacture of nanomedicines as part of the multinational B-SMART (Brain-Specific, Modular and Active RNA Therapeutics) translational research project
    Full story
  • Fifteen Years: Where Biotech Has Been And Where It Is Going

    Apr 4, 2017, 05:30 AM by Michael Croft

    Bio-IT World | 2017 marks the 15th anniversary of the Bio-IT World Conference & Expo in Boston. Several friends of Bio-IT World weigh in on the biggest opportunities and biggest roadblocks to bio-IT, research computing, drug discovery, and precision medicine in the next 15 years.

    Full story
  • Repositive Closes Series A Fundraising of £2.5 Million

    Apr 4, 2017, 04:28 AM by Michael Croft
    CAMBRIDGE, UNITED KINGDOM - Apr 4, 2017 - Repositive, the company that created the world’s largest portal for accessing human genomic research data, has closed a Series A funding round of £2
    Full story
  • Bristol-Myers Squibb Enters Collaboration To Leverage Foundation Medicine’s Molecular Information Platform

    Apr 3, 2017, 11:55 AM by Michael Croft

    Bio-IT World Brief | Bristol-Myers Squibb and Foundation Medicine announced a collaboration that leverages Foundation Medicine’s comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden and Microsatellite Instability in patients enrolled across clinical trials investigating Bristol-Myers Squibb’s cancer immunotherapies.

    Full story
  • Sharp announces £9 million investment

    Apr 3, 2017, 04:04 AM by Michael Croft
    RHYMNEY, UK - Apr 3, 2017 - Sharp Clinical Services (Sharp), part of UDG Healthcare plc (LON:UDG), has announced a £9 million  investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales
    Full story
  • Georgetown University, 10x Genomics, Jackson Laboratory, And More: News From March 2017

    Mar 30, 2017, 15:10 PM by Michael Croft

    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community including news from Georgetown University, 10x Genomics, Jackson Laboratory, and more.

    Full story
  • Ethical Assessment of Clinical Trials Following EU CTR Implementation - Are We Ready for Changes?

    Mar 30, 2017, 05:16 AM by Michael Croft
    BERLIN, GERMANY - Mar 30, 2017 - Since the publication of the EU Clinical Trial Regulation (CTR) 536/2014 in the Official Journal  a new scheme of Clinical Trial Application (CTA)  has been developed
    Full story
  • Cenduit to Showcase Advanced Solutions at IRT Europe 2017

    Mar 29, 2017, 16:34 PM by Michael Croft
    DURHAM, NC, UNITED STATES - Mar 29, 2017 -  WHAT:  Cenduit, LLC, the largest interactive response technology (IRT) specialist in the world, is showcasing its solutions and expertise at IRT Europe, April 4-5 in London, England
    Full story
  • Hi-C The Game-Changing Technique That Cracked the Zika-Mosquito Genome

    Mar 29, 2017, 14:34 PM by Michael Croft
    The Atlantic | "Hi-C" will make it much easier and cheaper to assemble all of an organism's genetic material from scratch.
    Full story
  • Fabric Genomics: New Identity, Partnerships, Products for Omicia

    Mar 29, 2017, 09:20 AM by Michael Croft

    Bio-IT World | Omicia rebranded last week, relaunching itself as Fabric Genomics with new products and new partnerships.

    Full story
  • Van Andel Research Institute installs world-class microscopes to enable discovery of the molecular basis of disease

    Mar 29, 2017, 00:38 AM by Michael Croft
    GRAND RAPIDS, MI, UNITED STATES - Mar 28, 2017 - Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building blocks in startling clarity and equips VARI’s growing team of scientists to push the limits of discovery in search of new treatments for diseases such as cancer and Parkinson’s
    Full story
  • TECHNIDATA launches new generation TDBactiLink, the middleware for bacteriology laboratories, and dedicated website: www.microbiology-middleware.com

    Mar 28, 2017, 12:26 PM by Michael Croft
    MONTBONNOT, FRANCE - Mar 28, 2017 -   A cost-effective middleware that brings laboratories to the forefront of technology  TDBactiLink is a dedicated middleware solution for bacteriology laboratories looking to make the most of technological advances and paperless organization without changing their existing laboratory information system (LIS)
    Full story
  • Silicon Valley’s Quest to Live Forever

    Mar 28, 2017, 10:15 AM by Michael Croft
    The New Yorker | Can billions of dollars' worth of high-tech research succeed in making death optional?
    Full story
  • «
  • 321
  • 322
  • 323
  • 324
  • 325
  • 326
  • 327 (current)
  • 328
  • 329
  • 330
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy